RCC Ablation Technique Influences Survival Time
One type thermal ablation appeared superior for cT1 a renal cell carcinoma patients.
Renal Cell Carcinoma
Study Comparing Targeted With Nontargeted Therapies in Patients With Metastatic RCC May Not Account for Recent Advances in Immunotherapy
There has been a sea change in outcomes from patients treated before 2007 for renal cell carcinoma, according to an expert.
RCC in Advanced CKD: A Transplant Dilemma
Non-dialysis patients with advanced CKD diagnosed with renal malignancies grapple with the dual threat of renal failure and cancer progression.
Sunitinib Timing for mRCC Does Not Affect CN Complication Rates
Investigators observed no differences in surgery time, blood loss, and hospital stay, with deferred vs upfront cytoreductive nephrectomy.
Fragmentation Pattern of Cell-Free DNA Can Reveal Cancer, Even at Early Stages
Machine learning algorithm detected 7 types of cancer in liquid biopsy and identified tissue of disease origin.
Solving the Obesity Paradox in Oncology
One potentially revolutionary hypothesis relates to the evolutionary processes involved in oncogenesis.
Partial Nephrectomy Preferable for T1a RCC
In a population-based study, PN was associated with improved cancer-specific survival by 56%.
Multidisciplinary Genetic Tumor Boards: Critical for Interpreting Tumor-Only Sequencing Results
One approach for improving recommendations based on tumor-only sequencing is use of a multidisciplinary genomic tumor board, in which researchers from a variety of backgrounds weigh in on the best way to interpret test results.
PN, RN Offer Comparable Long-Term Survival for T1b RCC
In a meta-analysis, partial and radical nephrectomy were associated with similar long-term overall survival, but cancer-specific survival was better with radical nephrectomy.
The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma
Updated guidelines advised against performing cytoreductive nephrectomy in poor-risk patients.
Next post in Renal Cell Carcinoma
